Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance

Research output: Contribution to journalReview articlepeer-review

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science